• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际头痛协会成人发作性偏头痛预防性治疗偏头痛发作的对照试验指南。

Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.

机构信息

Institute for Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Germany.

Headache Science Center, C. Mondino Foundation (IRCCS), Pavia, Italy.

出版信息

Cephalalgia. 2020 Sep;40(10):1026-1044. doi: 10.1177/0333102420941839. Epub 2020 Jul 28.

DOI:10.1177/0333102420941839
PMID:32722936
Abstract

Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the . Advances in drugs, devices, and biologicals, as well as novel trial designs, have prompted several updates over the nearly 30 years since, including most recently the (2018), the (2019), and (2019). The present update incorporates findings from new research and is intended to optimize the design of controlled trials of preventive pharmacological treatment of episodic migraine in adults. A guideline for clinical trials with devices will be published separately.

摘要

临床试验是头痛疾病治疗证据基础的关键组成部分。1991 年,国际头痛协会临床试验常务委员会制定并发布了第一版《头痛治疗临床试验方法的建议》。此后近 30 年来,随着药物、器械和生物制品的进步以及新的试验设计,该建议已经多次更新,最近的更新包括《头痛治疗临床试验方法的建议(2018 年)》《头痛治疗临床试验方法的建议(2019 年)》和《头痛治疗临床试验方法的建议(2019 年)》。本次更新纳入了新研究的结果,旨在优化成人发作性偏头痛预防性药物治疗的对照临床试验设计。器械临床试验指南将单独发布。

相似文献

1
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.国际头痛协会成人发作性偏头痛预防性治疗偏头痛发作的对照试验指南。
Cephalalgia. 2020 Sep;40(10):1026-1044. doi: 10.1177/0333102420941839. Epub 2020 Jul 28.
2
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.国际头痛学会成人慢性偏头痛预防性治疗对照试验指南。
Cephalalgia. 2018 Apr;38(5):815-832. doi: 10.1177/0333102418758283. Epub 2018 Mar 4.
3
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition.国际头痛学会关于儿童和青少年偏头痛预防性治疗对照试验指南,第 1 版。
Cephalalgia. 2019 Jun;39(7):803-816. doi: 10.1177/0333102419842188. Epub 2019 Apr 4.
4
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.国际头痛学会成人偏头痛急性发作治疗对照试验指南:第四版。
Cephalalgia. 2019 May;39(6):687-710. doi: 10.1177/0333102419828967. Epub 2019 Feb 26.
5
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults.成人慢性偏头痛预防性治疗对照试验指南。
Cephalalgia. 2008 May;28(5):484-95. doi: 10.1111/j.1468-2982.2008.01555.x. Epub 2008 Feb 20.
6
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition - An experience-based update.指南更新:《国际头痛学会儿童和青少年偏头痛预防性治疗对照试验指南》(第一版)——基于经验的更新。
Cephalalgia. 2023 May;43(5):3331024231178239. doi: 10.1177/03331024231178239.
7
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults.遵循 2008 年 IHS 成人慢性偏头痛预防性治疗药物对照试验指南。
Cephalalgia. 2019 Jul;39(8):1058-1066. doi: 10.1177/0333102419847751. Epub 2019 May 1.
8
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine.国际头痛学会关于偏头痛治疗用神经调控设备临床试验的指南。
Cephalalgia. 2021 Oct;41(11-12):1135-1151. doi: 10.1177/03331024211010413. Epub 2021 May 14.
9
Guidelines for controlled trials of drugs in migraine. First edition. International Headache Society Committee on Clinical Trials in Migraine.偏头痛药物对照试验指南。第一版。国际头痛协会偏头痛临床试验委员会。
Cephalalgia. 1991 Feb;11(1):1-12.
10
Have the IHS been followed? Laying the ground for the 4th edition.是否遵循了 IHS?为第四版奠定基础。
Cephalalgia. 2020 Jul;40(8):778-787. doi: 10.1177/0333102420906843. Epub 2020 Feb 14.

引用本文的文献

1
Biofeedback therapy using Cerebri for the prevention of migraine attacks in adults with episodic migraine (BioCer): a randomized, wait-list controlled trial - the study protocol.使用Cerebri进行生物反馈疗法预防发作性偏头痛成人的偏头痛发作(BioCer):一项随机、等待列表对照试验——研究方案
F1000Res. 2025 Aug 29;13:775. doi: 10.12688/f1000research.149807.2. eCollection 2024.
2
Assessing misophonia as a potential comorbidity in migraine patients compared to controls: a cross-sectional study.与对照组相比,评估恐音症作为偏头痛患者潜在共病的情况:一项横断面研究。
Front Neurol. 2025 Jul 16;16:1545520. doi: 10.3389/fneur.2025.1545520. eCollection 2025.
3
Psychological transdiagnostic factors and migraine characteristics as predictors of migraine-related disability.
作为偏头痛相关残疾预测因素的心理跨诊断因素和偏头痛特征
J Headache Pain. 2025 Jul 23;26(1):167. doi: 10.1186/s10194-025-02101-4.
4
A Prescribed Digital Health App and Number of Migraine Days: A Randomized Clinical Trial.一款处方数字健康应用程序与偏头痛天数:一项随机临床试验。
JAMA Netw Open. 2025 Jul 1;8(7):e2517708. doi: 10.1001/jamanetworkopen.2025.17708.
5
Noninvasive Vagus Nerve Stimulation for Cluster Headache and Migraine: A Health Technology Assessment.用于丛集性头痛和偏头痛的非侵入性迷走神经刺激:一项卫生技术评估
Ont Health Technol Assess Ser. 2025 May 1;25(2):1-177. eCollection 2025.
6
Calcitonin gene-related peptide-targeted therapies for migraine.降钙素基因相关肽靶向治疗偏头痛
Aust Prescr. 2025 Apr;48(2):40-46. doi: 10.18773/austprescr.2025.017.
7
Cluster Headache and Migraine Shared and Unique Insights: Neurophysiological Implications, Neuroimaging, and Biomarkers: A Comprehensive Review.丛集性头痛和偏头痛的共同与独特见解:神经生理学意义、神经影像学和生物标志物:综述
J Clin Med. 2025 Mar 21;14(7):2160. doi: 10.3390/jcm14072160.
8
Monthly Headaches and Severity in Patients on Galcanezumab or Traditional Preventive Migraine Medication: A 24-Month Claims and Electronic Health Records Study.接受加卡奈珠单抗或传统偏头痛预防性药物治疗患者的每月头痛情况及严重程度:一项为期24个月的索赔和电子健康记录研究
Neurol Ther. 2025 Jun;14(3):911-925. doi: 10.1007/s40120-025-00742-w. Epub 2025 Apr 11.
9
CROATIAN GUIDELINES FOR SPECIFIC PREVENTIVE TREATMENT OF MIGRAINE WITH MONOCLONAL ANTIBODIES TARGETING CALCITONIN GENE-RELATED PEPTIDE (CGRP) (EPTINEZUMAB, FREMANEZUMAB, AND GALCANEZUMAB) OR THE CGRP RECEPTOR (ERENUMAB).克罗地亚使用靶向降钙素基因相关肽(CGRP)的单克隆抗体(eptinezumab、fremanezumab和galcanezumab)或CGRP受体(erenumab)对偏头痛进行特定预防性治疗的指南
Acta Clin Croat. 2024 Oct;63(2):436-450. doi: 10.20471/acc.2024.63.02.22.
10
The effects of concurrent alpha-linolenic acid, L-carnitine supplementation on clinical symptoms, mental health, and quality of life in women with migraine: a randomized, triple-blind, placebo-controlled trial.同时补充α-亚麻酸和左旋肉碱对偏头痛女性临床症状、心理健康及生活质量的影响:一项随机、三盲、安慰剂对照试验
Nutr J. 2025 Mar 13;24(1):40. doi: 10.1186/s12937-025-01107-7.